Axolabs is the leading custom research organization providing high-end preclinical solutions and consultancy in the field of oligonucleotide therapeutics and nucleic acid medicines.

Business Continuity at Axolabs

We are committed to continuing our research services at Axolabs during the Covid-19 outbreak, while taking into account our staff’s safety and complying with the rules put in place by our health authorities and the Bavarian government.

Under the current circumstances we have modified our usual organization. Our non-lab-based staff is working from home whenever possible. In order to comply with the physical distance rules we have reorganized our on-site work places. If required we respond to the current local situation with shift operations. Amongst others, these measures have allowed us to maintain our services during the current pandemic. We will keep you informed in the event any constraints of our services become inevitable in the weeks to come.

Don’t hesitate to contact us with any questions.

Join a successful team (Job Offers)!


Scientific excellence

We leverage 21+ years of expertise in oligonucleotide research and drug development for the benefit of our customers.

Services across multiple disciplines

We deliver integrated solutions for preclinical research covering chemistry, biology and analytics of nucleic acid therapeutics.

Flexible and effective interaction with clients

Our custom-tailored blend of project management, scientific input and technological know-how facilitates optimal advancement of your projects.

High quality services and products

Axolabs‘ unique combination of a dedicated team with state-of-the-art equipment and well established processes ensures highest quality of our services and products.

From target to clinic

As a one-stop-shop we provide efficient and validated services towards the successful development of oligonucleotide-based therapeutics.